Ophthalmic Nanosystems with Antioxidants for the Prevention and Treatment of Eye Diseases
Source abstract
Abstract
Oxidative stress may induce a series of pathophysiological modifications that are directly involved in the development of ophthalmic diseases like age-related cataract, macular degeneration or diabetic retinopathy, considered to be responsible for the majority of vision loss cases. Although various treatment options for eye diseases are available, multiple factors could limit their efficacy. Recently, the accelerated development of ophthalmic nanosystems has provided new possibilities for overcoming the limitations of existing ocular drug delivery methods. This review evaluates the current status of ophthalmic nanosystems loaded with antioxidants for the prevention and treatment of several eye diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Sulfur Compounds in Biology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Technology and Biopharmaceutics, Iuliu Hatieganu University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
Department of Pharmacology, Physiology and Physiopathology, Iuliu Hatieganu University of Medicine and Pharmacy, 6 L. Pasteur Street, 400349 Cluj-Napoca, Romania
Department of Ophthalmology, Iuliu Hatieganu University of Medicine and Pharmacy, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania
Department of Pathophysiology, University of Agricultural Sciences and Veterinary Medicine, 3 Calea Manastur Street, 400374 Cluj-Napoca, Romania
Department of Analytical Chemistry, Iuliu Hatieganu University of Medicine and Pharmacy, 4 L. Pasteur Street, 400349 Cluj-Napoca, Romania
References (69)
Show source-provided references
1. World Health Organization (2019, October 08). Blindness and Vision Impairment. Available online: https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment.
2. Photoreceptor damage induced by low-intensity light: Model of retinal degeneration in mammals
3. Damage of photoreceptor-derived cells in culture induced by light emitting diode-derived blue light10.1038/srep05223 ↗
4. Retinal damage induced by commercial light emitting diodes (LEDs)10.1016/j.freeradbiomed.2015.03.034 ↗
5. Effects of white light-emitting diode (LED) exposure on retinal pigment epithelium in vivo10.1111/jcmm.13255 ↗
6. Oxidative stress and diabetic retinopathy10.1155/2007/43603 ↗
7. Laher, I. (2014). Treating retinopathies-nanotechnology as a tool in protecting antioxidants agents. Systems Biology of Free Radicals and Antioxidants, Springer Verlag.10.1007/978-3-642-30018-9 ↗
8. Light induces NLRP3 inflammasome activation in retinal pigment epithelial cells via lipofuscin-mediated photooxidative damage10.1007/s00109-015-1275-1 ↗
9. A2E, a byproduct of the visual cycle10.1016/S0042-6989(03)00475-9 ↗
10. Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation10.1016/S0891-5849(96)00555-2 ↗
11. Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells10.1038/s41419-018-0331-5 ↗
12. Nanoparticles for drug delivery to the anterior segment of the eye10.1016/j.addr.2017.04.001 ↗
13. Nanocarrier mediated retinal drug delivery: Overcoming ocular barriers to treat posterior eye diseases10.1002/wnan.1473 ↗
14. The blood-ocular barriers: Past, present and future10.1007/BF02569055 ↗
15. Pharmacokinetic aspects of retinal drug delivery10.1016/j.preteyeres.2016.12.001 ↗
16. Nanotechnology-based strategies for treatment of ocular disease10.1016/j.apsb.2016.09.001 ↗
17. Stealth liposomes: Review of the basic science, rationale and clinical applications, existing and potential
18. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery10.1016/j.jconrel.2013.11.020 ↗
19. CRISPR/Cas system for genome editing progress and prospects as a therapeutic tool10.1124/jpet.119.257287 ↗
20. Bioresponsive polyoxometalate cluster for redox-activated photoacoustic imaging-guided photothermal cancer therapy10.1021/acs.nanolett.7b00995 ↗
21. Intrathecal administration of nanoclusters for protecting neurons against oxidative stress in cerebral ischemia/reperfusion injury10.1021/acsnano.9b06780 ↗
22. Light-induced acid generation on a gatekeeper for smart nitric oxide delivery10.1021/acsnano.5b07483 ↗
23. Prolonged release period of nitric oxide gas for treatment of bacterial keratitis by amine-rich polymer decoration of nanoparticles10.1021/acs.chemmater.8b03332 ↗
24. Light-triggered nitric oxide (NO) release from photoresponsive polymersomes for corneal wound healing10.1039/C9SC04039K ↗
25. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery10.1016/j.jsps.2012.05.009 ↗
26. Improved ocular bioavailability of indomethacin by novel ocular drug carriers10.1111/j.2042-7158.1996.tb03911.x ↗
27. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers10.1023/B:PHAM.0000022411.47059.76 ↗
28. Bioavailability of Plant-Derived Antioxidants10.3390/antiox2040309 ↗
29. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo10.3109/03639045.2010.522193 ↗
30. In vitro stabilization and in vivo improvement of ocular pharmacokinetics of the multi-therapeutic agent baicalin: Delineating the most suitable vesicular systems10.1016/j.ijpharm.2018.01.041 ↗
31. Potential of CeCl3@mSiO2 nanoparticles in alleviating diabetic cataract development and progression10.1016/j.nano.2016.12.021 ↗
32. Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases10.5318/wjo.v5.i1.23 ↗
33. Protective effect of Coenzyme Q10 against oxidative damage in human lens epithelial cells by novel ocular drug carriers10.1016/j.ijpharm.2010.10.020 ↗
34. Kim, D., Maharjan, P., Jin, M., Park, T., Maharjan, A., Amatya, R., Yang, J., Min, K.A., and Shin, M.C. (2019). Potential albumin-based antioxidant nanoformulations for ocular protection against oxidative stress. Pharmaceutics, 11.10.3390/pharmaceutics11070297 ↗
35. Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief10.2147/IJN.S173198 ↗
36. Gelatin: A valuable protein for food and pharmaceutical industries: Review10.1080/20014091091904 ↗
37. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation10.1016/j.colsurfb.2014.09.042 ↗
38. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization10.2147/IJN.S114754 ↗
39. Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats10.1016/j.jphotobiol.2019.04.012 ↗
40. Novel Lutein Loaded Lipid Nanoparticles on Porcine Corneal Distribution10.1155/2014/304694 ↗
41. Topical nanodelivery system of lutein for the prevention of selenite-induced cataract10.1016/j.nano.2018.09.016 ↗
42. Co-encapsulated resveratrol and quercetin in chitosan and PEG modified chitosan nanoparticles: For efficient intraocular pressure reduction10.1016/j.ijbiomac.2017.04.117 ↗
43. In vitro antioxidant and anticataractogenic potential of silver nanoparticles biosynthesized using an ethanolic extract of Tabernaemontana divaricata leaves10.1016/j.biopha.2017.04.079 ↗
44. Design and characterization of an occular topical liposomal preparation to replenish the lipids of the tear film10.1167/iovs.14-14700 ↗
45. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels10.1016/j.ijpharm.2013.10.033 ↗
46. Multifunctional ZnO NPs-chitosan-gallic acid hybrid nanocoating to overcome contact lenses associated conditions and discomfort10.1016/j.jcis.2019.02.043 ↗
47. The anti-cataract molecular mechanism study in selenium cataract rats for baicalin ophthalmic nanoparticles10.2147/DDDT.S160524 ↗
48. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides10.1038/nnano.2006.91 ↗
49. Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria10.1016/j.biomaterials.2012.08.030 ↗
50. Zhou, X., Wong, L.L., Karakoti, A.S., Seal, S., and McGinnis, J.F. (2011). Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldr knockout mouse. PLoS ONE, 6.10.1371/journal.pone.0016733 ↗
51. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldr null mice10.1016/j.exer.2013.08.003 ↗
52. Baicalin from Scutellaria baicalensis blocks respiratory syncitial virus (RSV) infections and reduces inflammatory infiltration and lung injury in mice10.1038/srep35851 ↗
53. Nelson, B.C., Johnson, M.E., Walker, M., Riley, K.R., and Sims, C.M. (2016). Antioxidant cerium oxide nanoparticles in biology and medicine. Antioxidants, 5.10.3390/antiox5020015 ↗
54. Superoxide dismutase mimetic properties exhibited by vacancy. engineered ceria nanoparticles10.1039/b615134e ↗
55. Radical nanomedicine10.2217/17435889.1.4.399 ↗
56. Direct evidence for hydroxyl radical scavenging activity of cerium oxide nanoparticles10.1021/jp109819u ↗
57. Crystal plane effects of nano-CeO2 on its. antioxidant activity10.1039/C4RA06214K ↗
58. Cerium oxide nanoparticles scavenge nitric oxide radical ((no)-n-center dot)10.1039/c2cc30485f ↗
59. Curcumin: Therapeutical Potential in Ophthalmology
60. Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina10.1016/j.bbrc.2007.07.059 ↗
61. Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas10.1016/S0891-5849(99)00005-2 ↗
62. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the gren tea polyphenol, epigallocatechin 3-gallate10.1016/j.redox.2013.12.022 ↗
63. Possible biologic mechanisms for a protective role of xantophylls10.1093/jn/132.3.540S ↗
64. Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cells
65. Lutein prevents cataract development and progression in diabetic rats10.1007/s00417-008-0935-z ↗
66. Association between lutein and zeaxanthin status and the risk of cataract: A meta-analysis10.3390/nu6010452 ↗
67. Salehi, B., Mishra, A.P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Tsouh Foukou, P.V., Martins, N., and Sharifi-Rad, J. (2018). Resveratrol: A double-edged sword in health benefits. Biomedicines, 6.10.3390/biomedicines6030091 ↗
68. Silver enhances antibiotic activity against Gram-negative bacteria
69. Das, G., Patra, J.K., Debnath, T., Ansari, A., and Shin, H.-S. (2019). Investigation of antioxidant, antibacterial, antidiabetic and cytotoxicity potential of silver nanoparticles synthesized using the outer peel extract of Ananas comosus. PLoS ONE, 14.10.1371/journal.pone.0220950 ↗